This week on GFM Media: Vaccine-induced Autism – Dr. Andrew Wakefield Speaks
Dr. Andrew Wakefield is an academic gastroenterologist and perhaps the best known name in the realm of vaccine controversy (as well as being the most misused and abused name by the pro-vax establishment)
He received his medical degree from St. Mary’s Hospital Medical School (part of the University of London) in 1981, and pursued a career in gastrointestinal surgery with a particular interest in inflammatory bowel disease.
He qualified as Fellow of the Royal College of Surgeons in 1985 and in 1996 was awarded a Wellcome Trust Traveling Fellowship to study small-intestinal transplantation in Toronto, Canada.
He was made a Fellow of the Royal College of Pathologists in 2001 and has published over 140 original scientific articles, as well as two books on vaccine research, harm, corruption, and censorship.
In the scientific pursuit of possible links between childhood vaccines, intestinal inflammation, and neurologic injury in children, Dr. Andrew Wakefield magically became persona non grata and lost his job in the Department of Medicine at London’s Royal Free Hospital, as well as his country, his career, and his medical license.
All of this because his research made empirical links between gut disorders and vaccines—a heretical act no doubt, and intolerable to a multi-billion dollar industry that relies on the public’s blind trust and passive acquiescence.
Despite having his career wrongfully derailed and his name dragged through the mud by the paid liars within the medical fraternity and sellout mass-media ever since his initial research paper that sparked the furor, Wakefield has remained stalwart for the thousands of parents whose children have been harmed by the MMR and other vaccines.
Join us this Sunday night as we give Dr. Andrew Wakefield the floor to say the words prohibited and held as sacrilege by Big Pharma and the lapdog mainstream media.
Vaccine-Induced Autism with Dr Andrew Wakefield
Below you may listen to the episode free of charge. However, if you are financially able, we ask that you please consider the ‘Buy Now’ option and choose an amount for a fair exchange of energy, and to help keep GFM Radio going. Much love and gratitude for your kind contribution
Listen to Vaccine-Induced Autism with Dr Andrew Wakefield here:
Books By Dr. Andrew Wakefield:
Books About Vaccination By Other Authors:
Books About Vaccination Alternatives:
Documentaries About Vaccination:
CDC Whistleblower Admits MMR Vaccine Coverup:
Stephenie Seneff Talks About Autism and Vaccination:
Clinical Presentation and Histologic Findings at Ileocolonoscopy in Children with Autistic Spectrum Disorder and Chronic Gastrointestinal Symptoms
Arthur Krigsman, Marvin Boris, Alan Goldblatt3 and Carol Stott
GASTROINTESTINAL PATHOLOGY IN AUTISM SPECTRUM DISORDERS: THE VENEZUELAN EXPERIENCE
Lenny G. González, MD
Gastrointestinal comorbidity, autistic regression and Measles-containing vaccines: positive re-challenge and biological gradient
Andrew J. Wakefield, FRCS FRCPath; Carol Stottb, PhD; and Kirsten Limbc, BSc
Science regarding Treatment-Based Approaches in Autism
by Elizabeth Mumper, MD, Teresa Binstock, Jane Johnson
Commentary: MMR and Autism in Perspective: the Denmark Story
Stott C., Blaxill M., Wakefield AJ.
Journal of American Physicians and Surgeons 2004;9:89-91
Enterocolitis, autism and measles virus
Molecular Psychiatry. 2002;7:S44-46
Autism, Viral Infection and Measles-Mumps-Rubella Vaccination
Wakefield AJ and Montgomery SM.
Israeli Medical Association Journal 1999;1:183-187
Spontaneous Mucosal Lymphocyte Cytokine Profiles in Children with Autism and Gastrointestinal Symptoms: Mucosal Immune Activation and Reduced Counter Regulatory Interleukin-10
PAUL ASHWOOD,1,5 ANDREW ANTHONY,2 FRANCO TORRENTE,1,3 and ANDREW J. WAKEFIELD4
Small intestinal enteropathy with epithelial IgG and 41 complement deposition in children with regressive autism
43 F Torrente, P Ashwood, R Day1, N Machado, RI Furlano, A Anthony4, SE Davies4, AJ Wakefield3, 44 MA Thomson, JA Walker-Smith and SH Murch
Immune Response to Dietary Proteins, Gliadin and Cerebellar Peptides in Children with Autism
A. VOJDANIa,b,*, T. O’BRYANc, J.A. GREENd, J. MCCANDLESSe, K.N. WOELLERf, E. VOJDANIg, A.A. NOURIANa and E.L. COOPERb
THE IMMUNOLOGY OF IMMEDIATE AND DELAYED HYPERSENSITIVITY REACTION TO GLUTEN
A. VOJDANI, T. O’BRYAN1 and G.H. KELLERMANN2
THE IMMUNOLOGY OF GLUTEN SENSITIVITY BEYOND THE INTESTINAL TRACT
A. VOJDANI, T. O’BRYAN1 and G.H. KELLERMANN2
Gastrointestinal Pathology in Autism: Description and Treatment
Arthur Krigsman, MD
Bibliography of GI-related papers
Adams SJ, Burton N, Cutress A, et al. Development of double blind gluten and casein free test foods for use
in an autism dietary trial. J Hum Nutr Diet. 2008;21:374.
Afzal N, Murch S, Thirrupathy K, Berger L, Fagbemi A, Heuschkel R. Constipation with acquired megarectum in children with autism. Pediatrics. 2003 Oct;112(4):939-42.
Alberti A, Pirrone P, Elia M, Waring R, Romano C. Sulphation deficit in “low-functioning” autistic children: a pilot study. Biol Psychiatry 1999; 46 (3), 420-424.
Ashwood P, Wakefield AJ. Ileal and peripheral blood CD3+ cytokine profiles in children with regressive autism and gastrointestinal symptoms: Mucosal immune activation and reduced counter regulatory interleukin-10. Journal of Neuroimmunology. 2006;73:126-34.
Ashwood P, Anthony A, Pellicer AA, Torrente F, Walker-Smith JA, Wakefield AJ. Intestinal lymphocyte populations in children with regressive autism: evidence for extensive mucosal immunopathology. J Clin Immunol. 2003 Nov;23(6):504-17. PMID: 15031638.
Ashwood P, Anthony A, Torrente F, Wakefield AJ. Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: Mucosal immune activation and reduced counter regulatory interleukin-10. J Clin Immunol. 2004;24(6):664–73.
Ashwood P, Van de Water J. Is autism an autoimmune disease? Autoimmun Rev. 2004 Nov;3(7-8):557-62.
Ashwood P, Wakefield AJ. Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms. J Neuroimmunol. 2006 Apr;173(1-2):126-34.
Ashwood P, Willis S, Van de Water J. The immune response in autism: a new frontier for autism research. J Leuk Biol. 2006 Jul:80;1-15.
Balzola F, Barbon V, Repici A, Rizzetto M. Panenteric IBDlike disease in a patient with regressive autism shown for the first time by the wireless capsule enteroscopy: another piece in the jigsaw of this gut-brain syndrome? Am J Gastro. 2005;100(4):979–81.
Balzola F, Daniela C, Repici A, Barbon V, Sapino A, Barbera C, Calvo PL, Gandione M, Rigardetto R, Rizzetto M. Autistic enterocolitis: confirmation of a new inflammatory bowel disease in an Italian cohort of patients. Gastroenterology. 2005;128:Suppl.2;A-303.
Balzola F, et al. Autistic Enterocolitis in childhood: the early evidence of the later Crohn’s disease in autistic adulthood? Gastroenterology April 2007 Vol 132, N. 4, suppl 2 W 1100 A 660.
Balzola F, et al. Beneficial behavioural effects of IBD therapy and gluten/casein-free diet in an Italian cohort of patients with autistic enterocolitis followed over one year. Gastroenterology, April 2006 Vol 130 Number 4 suppl. 2 S1364 A-21.
Barcia G, Posar A, Santucci M, et al. Autism and coeliac disease. J Autism Dev Disord. 2008;38:407-408.
Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M. Effect of an enteric-coated fish-oil preparation on relapses in Crohn’s disease. N Engl J Med. 1996 Jun 13;334(24):1557-60.
Biller JA, Katz AJ, Flores AF, Buie TM, Gorbach SL. Treatment of recurrent Clostridium difficile colitis with
Lactobacillus GG. J Pediatr Gastroenterol Nutr. 1995 Aug;21(2):224-6.
Black C, Kaye J, Jick H. Relation of childhood gastrointestinal disorders to autism: Nested case-control study using data from the UK general practice research database. British Medical Journal. 2002;325(7361):419–21.
Bolte ER. Autism and Clostridium tetani. Med Hypotheses. 1998 Aug;51(2):133-44.
Bradstreet JJ, El Dahr JM, Anthony A, Kartzinel JJ, Wakefield, AJ. Detection of measles virus genomic RNA in cerebrospinal fluid of children with regressive autism: a report of three cases. J Am Phys Surg. 2004:9 (2): 38-45.
Buie TM. Gastroesophageal reflux in children with autism: how do children present and can one test these
children? J Pediatr Gastroenterol Nutr. 2005;41:505.
Buts JP, De Keyser N, De Raedemaeker L. Saccharomyces boulardii enhances rat intestinal enzyme expression by endoluminal release of polyamines. Pediatr Res. 1994 Oct;36(4):522-7.
Buts JP, De Keyser N. Effects of Saccharomyces boulardii on intestinal mucosa. Dig Dis Sci. 2006 Aug;51(8):1485-92.
Buts JP, De Keyser N, Marandi S, Hermans D, Sokal EM, Chae YH, Lambotte L, Chanteux H, Tulkens PM.
Saccharomyces boulardii upgrades cellular adaptation after proximal enterectomy in rats. Gut. 1999 Jul;45(1):89-96.
Chez MG, Dowling T, Patel PB, et al. Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children. Pediatr Neurol. 2007;36:361-365.
Cade R, Privette M, Fregly M, et al. Autism and schizophrenia: intestinal disorders. Nutritional Neuroscience. 2000;3:57-72.
Chess S, Fernandez P, Korn S. Behavioral consequences of congenital rubella. J Pediatr. 1978 Oct;93(4):699-703.
Christison GW, Ivany K. Elimination diets in autism spectrum disorders: any wheat amidst the chaff? J Dev
Behav Pediatr. 2006;27:S162-171.
Colon A, DoPalma J, Leftridge C. Intestinal lymphonodular hyperplasia of childhood: Patterns of presentation. Journal of Clinical Gastroenterology. 1991;13(2):163–6.
Connolly AM, Chez MG, Pestronk A, et al. Serum autoantibodies to brain in Landau-Kleffner variant, autism,
and other neurologic disorders. J Pediatr. 1999;134:607-613.
Connolly AM, Chez M, Streif EM, et al. Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy. Biol Psychiatry. 2006;59:354-363.
Dai D, Walker WA. Protective nutrients and bacterial colonization in the immature human gut. Adv Pediatr.
1999;46:353-82. PMID 10645469
D’Eufemia P, Celli M, Finocchiaro R, Pacifico L, Viozzi L, Zaccagnini M, Cardi E, Giardini O. Abnormal intestinal permeability in children with autism. Acta Paediatr. 1996 Sep;85(9):1076-9.
Drakes M, et al. Bacterial probiotic modulation of dendritic cells. Infect Immun. 2004 Jun;72(6):3299-309 PMID: 15155633.
Edwardes M, Baltzan M. Measles, mumps, and rubella (MMR) vaccine and autism. Argument is too simplistic. BMJ. 2001 Jul 21;323(7305):163; author reply 164.
Edwardes M, Baltzan M. MMR Immunization and Autism. JAMA 2001;285:2852-3.
Ehlin GGC, Montgomery SM, Ekbom A, Pounder RE, Wakefield AJ. The prevalence of gastrointestinal diseases in two British birth cohorts. Gut. 2003;52:1117-1121.
Elder JH, Shankar M, Shuster J, et al. The gluten-free, casein-free diet in autism: results of a preliminary double blind clinical trial. J Autism Dev Disord. 2006;36:413-420.
Erdeve O, et al. The probiotic effect of Saccharomyces boulardii in a pediatric age group. J Trop Pediatr. 2004 Aug;50(4):234-6. PMID: 15357564.
Esch BE, Carr JE. Secretin as a treatment for autism: a review of the evidence. J Autism Dev Disord.
Evangeliou A, Vlachonikolis I, Mihailidou H, et al. Application of a ketogenic diet in children with autistic
behavior: pilot study. J Child Neurol. 2003;18:113-118.
Ferrante P, Saresella M, Guerini FR, Marzorati M, Musetti MC, Cazzullo AG. Significant association of HLA A2-DR11 with CD4 naive decrease in autistic children. Biomed Pharmacother. 2003 Oct;57(8):372-4.
Fedorak RN, Madsen KL. Probiotics and the management of inflammatory bowel disease. Inflamm Bowel Dis. 2004 May;10(3):286-99. PMID: 15290926.
Forsberg G, et al. Presence of bacteria and innate immunity of intestinal epithelium in childhood celiac disease. Am J Gastroenterol. 2004 May;99(5):894-904. PMID: 15128357
Finegold SM, Molitoris D, Song Y, et al. Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis 2002 35(Suppl 1):S6-S16 PMID12173102.
Furlano R, Anthony A, Day, et al. Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. J Pediatr. 2001;138(3):366–72. PMID: 11241044
Gill HS, Guarner F. Probiotics and human health: a clinical perspective. Postgrad Med J. 2004 Sep;80(947):516-26. PMID: 15356352.
Goldman GS, Yazbak FE. An investigation of the association between MMR vaccination and autism in Denmark. J Am Phys Surg. 2004;9:70-75.
Gonzalez L, Lopez K, Navarro D, Negron L, Flores L, Rodriguez R, Martinez M, Sabra A. Endoscopic and
Histological Characteristics of the digestive mucosa in autistic children with gastrointestinal symptoms. Arch Venez Pueric Pediatr 69;1:19-25.
Gonzalez L, Lopez K, Martinez M, et al. Endoscopic and Histological Characteristics of the Digestive Mucosa in Autistic Children with gastro-Intestinal Symptoms: A Preliminary Report. GEN Suplemento Especial de
Goodwin MS, Cowen MA, Goodwin TC. Malabsorption and cerebral dysfunction. J Autism Child Schizophr. 1971;1:48-62.
Gottschall, Elaine G. Breaking the Vicious Cycle: Intestinal Health Through Diet. Ontario: Kirkton Press. 1994.
Gupta S, Aggarwal S, Rashanravan B, Lee T. Th1- and Th2- like cytokines in CD4+ and CD8+ T cells in autism. J Neuroimmunol. 1998 May 1;85(1):106-9.
Hadjivassiliou M et al. Does cryptic gluten sensitivity play a part in neurological illness? Lancet. 1996 Feb
10;347(8998):369-71. PMID: 8598704
Handen BL, Melmed RD, Hansen RL, et al. A doubleblind, placebo-controlled trial of oral human immunoglobulin for gastrointestinal dysfunction in children with autistic disorder. J Autism Dev Disord. 2009;39:796-805.
Haskey N, Dahl WJ. Synbiotic therapy: a promising new adjunctive therapy for ulcerative colitis. Nutr Rev. 2006 Mar;64(3):132-8.
Hassall E. Decisions in diagnosing and managing chronic gastroesophageal reflux disease in children. J Pediatr. 2005 Mar;146(3 Suppl):S3-12.
Horvath K et al. Gastrointestinal abnormalities in children with autistic disorder. J Pediatr. 1999 Nov;135(5):559-63. PMID: 10547242.
Horvath K, Perman JA. Autism and gastrointestinal symptoms. Curr Gastroenterol Rep. 2002 Jun;4(3):251-8. PMID: 12010627
Horvath K, Perman JA. Autistic disorder and gastrointestinal disease. Curr Opin Pediatr. 2002 Oct;14(5):583-7. PMID:12352252
Horvath K, Papadimitriou JC, Rabsztyn A, et al. Gastrointestinal abnormalities in children with autistic
disorder. J Pediatr. 1999;135:559-563.
Imani F, Kehoe KE. Infection of human B lymphocytes with MMR vaccine induces IgE class switching. Clin Immunol. 2001;100(3):355-61.
Isolauri E, Juntunen M, Rautanen T, Sillanaukee P, Koivula T. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics. 1991 Jul;88(1):90-7.
Iacono G et al. Intolerance of cow’s milk and chronic constipation in children. N Engl J Med. 1998 Oct
15;339(16):1100-4. PMID: 9770556.
Iseri SO, Sener G, Saglam B, Gedik N, Ercan F, Yegen BC. Oxytocin ameliorates oxidative colonic inflammation by a neutrophil-dependent mechanism. Peptides. 2005 Mar;26(3):483-91.
Jyonouchi H, Geng L, Ruby A, Zimmerman-Bier B. Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention. Neuropsychobiology. 2005;51(2):77-85.
Jyonouchi H, Geng L, Ruby A, Reddy C, Zimmerman-Bier B. Evaluation of an association between gastrointestinal symptoms and cytokine production against common dietary proteins in children with autism spectrum disorders. J Pediatr. 2005 May;146(5):605-10.
Jyonouchi H, Sun S, Itokazu N. Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder. Neuropsychobiology. 2002;46(2):76-84.
Jyonouchi H, Sun S, Le H. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J Neuroimmunol. 2001 Nov 1;120(1-2):170-9.
Knivsberg AM, Reichelt KL, Hoien T, Nodland M. A randomised, controlled study of dietary intervention in
autistic syndromes. Nutr Neurosci. 2002 Sep;5(4):251-61.
Knivsberg AM, Reichelt KL, Nodland M, et al. Autistic symptoms and diet: a follow-up study. Scand J Ed
Knivsberg AM et al. Reports on dietary intervention in autistic disorders. Nutr Neurosci. 2001;4(1):25-37. PMID: 11842874
Knivsberg AM, Wiig K, Lind G, et al. Dietary intervention in autistic syndromes. Brain Dysfunction. 1990;3:315-327.
Kokkonen J, Karttunen T. Lymphonodular hyperplasia on the mucosa of the lower gastrointestinal tract in children: An indication of enhanced immune response? Journal of Pediatric Gastroenterology and Nutrition.
Kruis W. Antibiotics and probiotics in inflammatory bowel disease. Aliment Pharmacol Ther. 2004 Oct;20 Suppl 4:75-8. PMID: 15352898
Kuddo T, Nelson KB. How common are gastrointestinal disorders in children with autism? Curr Opin Pediatr. 2003;15(3):339–43.
Kushak R, Winter H, Farber N, Buie T. Gastrointestinal symptoms and intestinal disaccharidase activities in children with autism. Abstract of presentation to the North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition, Annual Meeting, October 20-22, 2005, Salt Lake City, Utah.
Liu Z, Li N, Neu J. Tight junctions, leaky intestines, and pediatric diseases. Acta Paediatr. 2005 Apr;94(4):386-93.
Lucarelli S, Frediani T, Zingoni AM, et al Food allergy and infantile autism. Panminerva Med. 1995 Sep;37(3):137-41. PMID: 8869369
Macdonald A. Omega-3 fatty acids as adjunctive therapy in Crohns disease. Gastroenterol Nurs. 2006 Jul-
MacFabe DF, Cain DP, Rodriguez-Capote K, Franklin AE, Hoffman JE, Boon F, Taylor AR, Kavaliers M, Ossenkopp KP. Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav Brain Res. 2007 Jan 10; 176 (1):149-69. PMID: 16950524.
Majamaa H, Isolauri E, Saxelin M, Vesikari T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr. 1995 Apr;20(3):333-8.
Mehler MF, Kessler JA. Cytokines in brain development and function. Adv Protein Chem. 1998;52:223-51.
Melmed R, Schneider C, Fabes R, Phillips L, Reichelt K. Metabolic markers and gastrointestinal symptoms in children with autism and related disorders. J Pediatr Gastroenterol Nutr. 2000;31(Suppl 2):S31–2.
Millward C, Ferriter M, Calver S, et al. Gluten- and casein-free diets for autistic spectrum disorder. Cochrane
Database Syst Rev. 2008;(2):CD003498.
Molloy C, Morrow A, Meinzen-Derr J, Schleifer K, Dienger K, Manning-Courtney P, Altaye M, Wills-Karp M. Elevated cytokine levels in children with autism spectrum disorder. J Neuroimmunology. 2006;172:198-205.
Molloy C, Manning-Courtney P. Prevalence of chronic gastrointestinal symptoms in children with autism and autistic spectrum disorders. Autism. 2003;7(2):165–71.
Montgomery SM, Morris DL, Pounder RE, Wakefield AJ. Paramyxovirus infections in childhood and subsequent inflammatory bowel disease. Gastroenterology. 1999 Apr;116(4):796-803.
Montgomery SM, Lambe M, Wakefield AJ, Pounder RE, Ekbom A. Siblings and the risk of Inflammatory Bowel Disease. Scandinavian Journal of Gastroenterology 2002;37:1301-1308
North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Evaluation and treatment
of constipation in children: summary of updated recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2006 Sep;43(3):405-7.
O’Banion D, Armstrong B, Cummings RA, et al. Disruptive behavior: a dietary approach. J Autism Child Schizophr. 1978;8:325-337.
Pardo CA, Vargas DL, Zimmerman AW. Immunity, neuroglia and neuroinflammation in autism. Int Rev Psychiatry. 2005 Dec;17(6):485-95.
Parracho HM, Bingham MO, Gibson GR, McCartney AL. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol. 2005 Oct;54(Pt 10):987-91.
Plesner A-M, Hansen FJ, Taadon K, Nielson LH, Larsen CB, Pedersen E. Gait disturbance interpreted as cerebellar ataxia after MMR vaccination at 15 months of age: a follow-up study. Acta Paediatrica. 2000;89:58-63.
Quigley EM, Hurley D. Autism and the gastrointestinal tract. Am J Gastroenterol. 2000 Sep;95(9):2154-6. PMID: 11007210
Ratliff-Schaub K, Carey T, Reeves GD, et al. Randomized controlled trial of transdermal secretin on behavior
of children with autism. Autism. 2005;9:256-265.
Reichelt KL, Knivsberg AM. Can the pathophysiology of autism be explained by the nature of the discovered urine peptides? Nutr Neurosci. 2003 Feb;6(1):19-28. PMID:12608733
Reichelt KL, Ekrem J, Scott H. Gluten, milk proteins and autism: dietary intervention effects on behavior and peptide secretion. J Appl Nutr. 1990;42:1-11.
Richler J, Luyster R, Risi S, et al. Is there a ‘regressive phenotype’ of Autism Spectrum Disorder associated with the measles-mumps-rubella vaccine? A CPEA Study. Journal of Autism and Developmental Disorders. 2006;36(3):299–316.
Romano C, Cucchiara S, Barabino A, Annese V, Sferlazzas C. Usefulness of omega-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn’s disease: a double-blind, randomized, placebo-controlled study. World J Gastroenterol. 2005 Dec 7;11(45):7118-21.
Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet. 1994 Oct 15;344(8929):1046-9.
Schneider CK, Melmed RD, Barstow LE, Enriquez FJ, Ranger-Moore J, Ostrem JA. Oral human immunoglobulin for children with autism and gastrointestinal dysfunction: a prospective, open-label study. J Autism Dev Disord. 2006;36:1053-1064.
Shenoy S, Arnold S, Chatila T. Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndrome. Journal of Pediatrics. 2000;136(5):682–7.
Shultz SR, MacFabe DF, Ossenkopp KP, Scratch S, Whelan J, Taylor R, Cain DP. Intracerebroventricular injection of propionic acid, an enteric bacterial metabolic end-product, impairs social behavior in the rat: Implications for an animal model of autism. Neuropharmacology. 2008 May;54(6):901-11. PMID: 18395759.
Sido B, Hack V, Hochlehnert A, Lipps H, Herfarth C, Droge W. Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease. Gut. 1998 Apr;42(4):485-92.
Singh VK. Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism. J Neuroimmunol. 1998 May 1;85(1):106-9.
Singh VK, Jensen RL. Elevated levels of measles antibodies in children with autism. Pediatr Neurol. 2003 Apr;28(4):292-4.
Singh VK, Lin SX, Yang V. Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism. Clin Immun Immunopathol. 1998 Oct:89(1):105-108.
Singh VK, Lin SX, Newell E, Nelson C. Abnormal measles-mumps-rubella antibodies and CNS autoimmunity in children with autism. J Biomed Sci. 2002;9:359-364.
Singh VK, Warren RP, Odell JD, Warren WL, Cole P. Antibodies to myelin basic protein in children with autistic behavior. Brain Behav Immun. 1993 Mar;7(1):97-103.
Smeeth L. Measles, mumps, and rubella (MMR) vaccine and autism: ecological studies cannot answer main question. BMJ 2001 Jul;323(7305):163.
Song Y, Liu C, Finegold SM. Real-time PCR quantitation of clostridia in feces of autistic children. Appl Environ Microbiol. 2004 Nov;70(11):6459-65.
Sougioultzis S, Simeonidis S, Bhaskar KR, Chen X, Anton PM, Keates S, Pothoulakis C, Kelly CP. Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NFkappaB-mediated IL-8 gene expression. Biochem Biophys Res Commun. 2006 Apr 28;343(1):69-76.
Spitzer WO. Measles, mumps, and rubella vaccination and autism. N Engl J Med. 2003 Mar 6;348(10):951-4; author reply 951-4.
Sponheim E. [Gluten-free diet in infantile autism. A therapeutic trial]. [In Norwegian.] Tidsskr Nor Laegeforen. 1991;111:704-707.
Stott C, Blaxill M, Wakefield AJ. MMR and Autism in Perspective: the Denmark Story. Journal of American Physicians and Surgeons. 2004;9:89-91
Stubbs EG, Budden SS, Burger DR, et al. Transfer factor immunotherapy of an autistic child with congenital cytomegalovirus. J Autism Dev Disord. 1980;10:451-458.
Swedo SE, Leonard HL, Garvey M, Mittleman B, Allen AJ, Perlmutter S, Lougee L, Dow S, Zamkoff J, Dubbert BK. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry. 1998 Feb;155(2):264-71.
Swedo SE, Leonard HL, Rapoport JL. The pediatricautoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) subgroup: separating fact from fiction. Pediatrics. 2004 Apr;113(4):907-11.
Swedo SE, Grant PJ. Annotation: PANDAS: a model for human autoimmune disease. J Child Psychol Psychiatry. 2005 Mar;46(3):227-34.
Taylor B, Miller E, Lingam R, Andrews N, Simmons A, Stowe J. Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: Population study. British Medical Journal. 2002;16(324:7334):393–6.
Torrente F, Anthony A, Heuschkel RB, Thomson M, Ashwood P, Murch SH. Focal-enhanced gastritis in regressive autism with features distinct from Crohn’s disease and helicobacter pylori gastritis. Am J Gastroenterol. 2004;99(4):598–605.
Torrente F, Ashwood P, Day R, et al. Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Mol Psychiatry. 2002;7(4):375-82, 334. PMID: 11986981
Torrente F, Machado N, Perez-Machado M, Furlano R, Thomson M, Davies S, Wakefield AJ, Walker-Smith JA, Murch SH. Enteropathy with T cell infiltration and epithelial IgG deposition in autism. Molecular Psychiatry. 2002;7:375-382
Turunen S, Kartunnen T, Kokkonen J. Lymphoid nodular hyperplasia and cows milk hypersensitivity in children with chronic constipation. Journal of Pediatrics. 2004;145(3):606–11. Uhlmann V et al. Potential viral pathogenic mechanism for new variant inflammatory bowel disease. Mol Pathol. 2002 Apr;55(2):84-90. PMID: 11950955
Valicenti-McDermott M, McVicar K, Rapin I, Wershil BK, Cohen H, Shinnar S. Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease. J Dev Behav Pediatr. 2006 Apr;27(2 Suppl):S128-36.
Valicenti-McDermott MD, Kathryn McVicar K, Cohen HJ, Wershil BK, Shlomo Shinnar S. Gastrointestinal Symptoms in Children with an Autism Spectrum Disorder and Language Regression. Pediatr Neurol. 2008;39: 392–8.
Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol. 2005 Jan;57(1)67-81.
Vojdani A, Campbell AW, Anyanwu E, Kashanian A, Bock K, Vojdani E. Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A. J Neuroimmunol. 2002 Aug;129(1-2):168-77.
Vojdani A, Pangborn JB, Vojdani E, et al. Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are major instigators of autoimmunity in autism. Int J Immunopathol Pharmacol. 2003;16:189-199.
Vojdani A, O’Bryan T, Green JA, et al. Immune response to dietary proteins, gliadin and cerebellar peptides in children with autism. Nutr Neurosci. 2004;7:151-161.
Vojdani A, Bazargan M, Vojdani E, et al. Heat shock protein and gliadin peptide promote development of peptidase antibodies in children with autism and patients with autoimmune disease. Clin Diagn Lab Immunol. 2004;11:515-524.
Wakefield AJ, Ashwood P, Limb K, Anthony A. The significance of ileo-colonic lymphoid nodular hyperplasia in children with autistic spectrum disorder. Eur J Gastroenterol Hepatol. 2005 Aug;17(8):827-36.
Wakefield AJ. Enterocolitis, autism and measles virus. Mol Psychiatry. 2002;7 Suppl 2:S44-6. PMID: 12142948
Wakefield AJ. The gut-brain axis in childhood developmental disorders. J Pediatr Gastroenterol Nutr. 2002 May-Jun;34 Suppl 1:S14-7. PMID: 12082381.
Wakefield AJ et al. Review article: the concept of enterocolonic encephalopathy, autism and opioid receptor ligands. Aliment Pharmacol Ther 2002 16(4):663-74. PMID 11929383
Wakefield AJ et al. Enterocolitis in children with developmental disorders. Am J Gastroenterol. 2000
Sep;95(9):2285-95. PMID: 11007230.
Wakefield AJ. Entero-colitis, Autism and Measles Virus. Consensus in Child Neurology. 2002;6:74-77
Wakefield AJ. Enterocolitis, autism and measles virus. Molecular Psychiatry. 2002;7:S44-46
Wakefield AJ, Murch S, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 1998;351(9103):637–41. PMID: 9500320
Wakefield AJ, Montgomery SM. Measles, mumps, rubella vaccine: through a glass, darkly. Adverse Drug React Toxicol Rev. 2000:19(4): 265-83.
Wakefield AJ. MMR vaccination and autism. Lancet. 1999;354:949-50 (letter)
Wakefield AJ. The New Autism (Invited Article) Clinical Child Psychology & Psychiatry 2002;7:518-528
Wakefield AJ. The significance of ileocolonic lymphoid nodular hyperplasia in children with autistic spectrum disorder. (letter) Eur J Gastro Hep. 2006;18:571-574.
Wakefield AJ. Autistic enterocolitis: is it a histopathological entity? Histopathology 2006;50:380-384.
Wakefield AJ, Collins I, Ashwood P. The Gut-Brain Axis in Childhood Developmental Disorders: Viruses and Vaccines. Invited chapter in Infectious Disease and Neuropsychiatric Disorders. Chapter 21, pp 198-206
Wakefield AJ, Montgomery SM. Autism, viral infection and measles mumps rubella vaccination. Israeli Medical Association Journal. 1999;1:183-187.
Wakefield AJ., Stott C., Limb K. Gastrointestinal co-morbidity, autistic regression and Measles-containing vaccines: positive re-challenge and biological gradient effects. Medical Veritas 2006;3:796-802
Walker-Smith J. Autism, inflammatory bowel disease and MMR vaccine.
Weibel RE, Caserta V, Benor DE. Acute encephalopathy followed by permanent brain injury or death associated with further attenuated measles vaccines: a review of claims submitted to the National Vaccine Injury Compensation Programme. Paediatrics. 1998;101:383-387.
Welch MG, Welch-Horan TB, Anwar M, Anwar N, Ludwig RJ, Ruggiero DA. Brain effects of chronic IBD in areas abnormal in autism and treatment by single neuropeptides secretin and oxytocin. J Mol Neurosci 2005; 25(3):259-74.
Whiteley P, Rodgers J, Savery D, et al. A gluten-free diet as an intervention for autism and associated spectrum disorders: preliminary findings. Autism. 1999;3:45.
Williams C, Nicholls S. Endoscopic features of chronic inflammatory bowel disease in childhood. Baillieres Clinical Gastroenterology. 1994;8(1):121–31.
Williams KW, Wray JJ, Wheeler DM. Intravenous secretin for autism spectrum disorder. Cochrane Database
Syst Rev. 2005;(3):CD003495.
Yazbak FE. Measles, mumps, and rubella (MMR) vaccine and autism. MMR cannot be exonerated without explaining increased incidence of autism. BMJ. 2001;323(7305):163-4.
Zimmerman AW, Jyonouchi H, Comi AM, Connors SL, Milstien S, Varsou A, Heyes MP. Cerebrospinal fluid and serum markers of inflammation in autism. Pediatr Neurol. 2005 Sep;33(3):195.
Thanks for listening to Vaccine-Induced Autism with Dr. Andrew Wakefield.
Please leave your comments below, and share with your friends.
– Aimee and Brendan